User evaluation of the Hypo‐METRICS app: A tool for real‐time symptom reporting of hypoglycaemia
Authors:
- Monika CiglerMCMonika Cigler
- Uffe SøholmUSUffe Søholm
- Melanie BroadleyMBMelanie Broadley
- François PouwerFPFrançois Pouwer
- Evertine J. AbbinkEAEvertine J. Abbink
- Namam AliNANamam Ali
- Bastiaan E. de GalanBGBastiaan E. de Galan
- Eric RenardEREric Renard
- Mark EvansMEMark Evans
- Julie Maria Bøggild BrøsenJBJulie Maria Bøggild Brøsen
- Ulrik Pedersen‐BjergaardUPUlrik Pedersen‐Bjergaard
- Rory J. Mc CrimmonRCRory J. Mc Crimmon
Open Access
- 30 December 2025
- journal article
- Published by Wiley in Diabetic Medicine
- Vol. 43 (3) , e70185
Abstract
Aims: Hypoglycaemia remains a barrier to optimal diabetes management, with few tools for capturing real‐time person‐reported hypoglycaemia (PRH). This study evaluated the Hypo‐METRICS app, originally developed for a multinational 10‐week prospective study of hypoglycaemia. It enables real‐time reporting of hypoglycaemic episodes and their impact on daily functioning using Ecological Momentary Assessment (EMA), thereby overcoming limitations of retrospective self reports. Methods: After completing the Hypo‐METRICS study, 120 participants with type 1 diabetes mellitus (T1D) or type 2 diabetes mellitus (T2D) from Austria, Denmark, the Netherlands, and the United Kingdom were invited to complete a web‐based questionnaire assessing app content, functionality, intervention effects, user engagement and the influence of the Covid‐19 pandemic. Results: Ninety‐six participants (80%; 29 T1D, 67 T2D) completed the questionnaire (40% women; mean age 57.2 ± 16.1 years; 26% impaired hypoglycaemia awareness; HbA1c 60 ± 13 mmol/mol (7.6 ± 1.1%); diabetes duration 20.4 ± 11.3 years). App content and functionality were rated highly (>8/10 and >7/10, respectively). Some reported declining engagement, likely due to study length. COVID‐19 had a minimal impact on app use. Conclusions: The Hypo‐METRICS app was well accepted, with strong ratings for usability and functionality. Given its unique strengths, the app has the potential to become an essential instrument for researchers aiming to capture the real‐world burden and impact of hypoglycaemia.Keywords
Funding Information
- European Federation of Pharmaceutical Industries and Associations
This publication has 29 references indexed in Scilit:
- The impact of hypoglycaemia on daily functioning among adults with diabetes: a prospective observational study using the Hypo-METRICS appDiabetologia, 2024
- Nocturnal hypoglycemia is associated with next day cognitive performance in adults with type 1 diabetes: Pilot data from the GluCog studyThe Clinical Neuropsychologist, 2024
- The power of the patient’s voice in the modern health care systemInternational Journal for Quality in Health Care, 2022
- The impact of hypoglycaemia on quality of life outcomes among adults with type 1 diabetes: A systematic reviewDiabetes Research and Clinical Practice, 2021
- Reducing the burden of hypoglycaemia in people with diabetes through increased understanding: design of the Hypoglycaemia REdefining SOLutions for better liVEs (Hypo‐RESOLVE) projectDiabetic Medicine, 2020
- Effectiveness of psychoeducational interventions for the treatment of diabetes-specific emotional distress and glycaemic control in people with type 2 diabetes: A systematic review and meta-analysisPrimary Care Diabetes, 2019
- Advanced Technology in the Management of Diabetes: Which Comes First—Continuous Glucose Monitor or Insulin Pump?Current Diabetes Reports, 2019
- Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin InjectionsJAMA, 2017
- Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled TrialDiabetes Therapy, 2016
- Measuring Change in Quality of Life: Bias in Prospective and Retrospective EvaluationValue in Health, 2015